Treatment of HCV disorders
Details for Australian Patent Application No. 2006204524 (hide)
International Classifications
Event Publications
21 June 2007 PCT application entered the National Phase
PCT publication WO2006/072562 Priority application(s): WO2006/072562
27 May 2010 Application Accepted
Published as AU-B-2006204524
23 September 2010 Standard Patent Sealed
23 September 2010 Corrigenda
Applications Accepted - Name Index Under the name Novartis AG, Application No. 2006204524, under INID (32) correct the date to 04.01.05
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006204523-X-ray structure of human FPPS and use for selecting FPPS binding compounds
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser